Roper Martin reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients director Martin Roper received an equity grant of 5,801 shares of Common Stock as an annual award for his board service. The shares were granted at no cash cost to him as compensation, not as an open‑market purchase. After this award, he directly holds 33,271 shares, including 3,180 restricted stock units.
Siwak Todd B. reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients, Inc. director Todd B. Siwak received an annual award of 5,801 shares of common stock. The shares were granted at $0.00 per share as unrestricted stock in connection with his service as a director.
Following this grant, Siwak directly holds 10,040 shares of MGP Ingredients common stock. As of the same date, he also indirectly holds 3,046 shares through a trust.
LOPEZ GERARDO I reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients, Inc. director Gerardo I. Lopez received an award of 5,801 shares of Common Stock as part of his annual compensation for board service. The shares were granted at no cash cost to him. Following this grant, he directly holds 12,262 shares of Common Stock, which includes 3,180 restricted stock units.
MGP Ingredients, Inc. reported that director Thomas A. Gerke received an annual award of common stock. He acquired 5,801 shares of common stock as a grant in connection with his service as a director, with no cash price per share reported in the transaction. Following this award, he directly owns 17,118 common shares. This is a compensation-related stock grant rather than an open-market purchase or sale.
Romero Mercedes reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients, Inc. director Mercedes Romero received an annual award of 5,801 shares of common stock. The shares were granted at no cash cost as unrestricted stock in connection with her service as a director, bringing her directly held stake to 5,801 shares.
MGP Ingredients Inc filed an insider report identifying Mercedes Romero as a company director. The filing is a Form 3, which lists her as a reporting person but shows no common stock or derivative transactions. The transaction summary indicates zero buys, zero sells, and a neutral net share position.
MGP Ingredients, Inc. held its 2026 Annual Meeting of Stockholders on May 13, 2026. Stockholders elected four Group A directors representing common stock and five Group B directors representing preferred stock. All director nominees received sufficient support to be elected.
Stockholders ratified KPMG LLP as independent registered public accounting firm for 2026, with 19,483,305 common shares voting for, 204,226 against and 2,763 abstaining, plus unanimous preferred support. They also approved, on an advisory basis, executive compensation and approved the Amended and Restated 2024 Equity Incentive Plan.
Francis Julie Maria reported acquisition or exercise transactions in this Form 4 filing.
MGP Ingredients Inc. reported that President & CEO Julie Maria Francis received a grant of 150,000 stock options to buy Common Stock at $19.40 per share. The options expire on May 1, 2036 and will vest on a pro rata basis on each of May 1, 2029 and May 1, 2030.
Following this filing, Francis directly holds 109,830 shares of Common Stock, which include 51,156 restricted stock units and 58,674 performance stock units that remain subject to time-based vesting. This Form 4 reflects a compensation-related equity award rather than an open‑market trade.
MGP Ingredients reported a sharp quarterly loss driven by major write-downs in its branded spirits business. Sales for the quarter ended March 31, 2026 fell 13% to $106.4M, as brown goods revenue in Distilling Solutions dropped 56% on softer customer demand and elevated industry barrel inventories.
Gross margin declined to 31.6% from 35.6%. The company recorded $179.5M of goodwill and other long-lived asset impairment in Branded Spirits, pushing operating results to a loss of $173.2M and net loss to $134.8M (or $(6.30) per share), compared with a $3.1M loss a year ago.
Ingredient Solutions was a bright spot, with sales up 29% to $34.2M and gross profit up 56%, helped by stronger specialty wheat proteins and starches. Operating cash flow declined to $7.0M, but MGP ended the quarter with $10.4M in cash, $252.5M of total debt, and significant unused capacity on its revolving credit facility and note purchase program.
MGP Ingredients, Inc. reported first-quarter 2026 results marked by large non-cash impairment charges but reaffirmed its full-year 2026 outlook and declared a $0.12 dividend. Sales fell 13% to $106.4 million, pressured by weaker brown goods in Distilling Solutions, while Ingredient Solutions grew 29%.
The company recorded $179.5 million of goodwill and indefinite-lived intangible impairments and a $26.9 million fixed-asset impairment, driving a net loss of $134.8 million, or $(6.30) per share. On an adjusted basis, net income was $3.3 million and adjusted basic EPS was $0.15, with adjusted EBITDA down 31% to $15.0 million. Management reaffirmed 2026 guidance for sales of $480–$500 million, adjusted EBITDA of $90–$98 million, and adjusted basic EPS of $1.50–$1.80.